Edition:
India

Rohto Pharmaceutical Co Ltd (4527.T)

4527.T on Tokyo Stock Exchange

3,655JPY
18 Sep 2020
Change (% chg)

¥-15 (-0.41%)
Prev Close
¥3,670
Open
¥3,660
Day's High
¥3,680
Day's Low
¥3,605
Volume
560,700
Avg. Vol
290,490
52-wk High
¥3,680
52-wk Low
¥2,477

Summary

Name Age Since Current Position

Kunio Yamada

64 2019 Chairman of the Board, Chief Executive Officer, Representative Director

Masashi Sugimoto

58 2019 President, Chief Operating Officer, Representative Director

Shinichi Kunisaki

64 2018 President of Subsidiary, Director

Hidetoshi Segi

57 2019 Chief Information Officer, Director of Business Planning, Director

Lekh Raj Juneja

68 2014 Vice President, Chief Health Officer, Director

Masaya Saito

56 2018 Vice President, President of Subsidiary, Director

Masako Rikiishi

61 2018 Director of Product Marketing, Director

Hideto Uemura

61 2018 Director of Business Strategy Promotion Unit, Manager of Ueno Technology Center, Director

Tetsumasa Yamada

70 2018 Director of Regenerative Medicine Research Planning, Director

Akie Iriyama

47 2019 Independent Director

Mari Matsunaga

65 2014 Independent Director

Shingo Torii

67 2015 Independent Director

Masumi Inoue

2019 Director of Accounting & Finance

Biographies

Name Description

Kunio Yamada

Mr. Kunio Yamada has been serving as Chairman of the Board, Chief Executive Officer and Representative Director in ROHTO Pharmaceutical Co., Ltd., since June 2019. He joined the Company in 1980. His previous titles include Senior Managing Director, Chief Director of Health Care Business Promotion and Vice President in the Company. He obtained his Bachelor's degree from the University of Tokyo and MBA from Keio University.

Masashi Sugimoto

Mr. Masashi Sugimoto has been serving as President, Chief Operating Officer and Representative Director in ROHTO Pharmaceutical Co., Ltd., since June 2019. He used to work for Takeda Consumer Healthcare Co., Ltd. and other company.

Shinichi Kunisaki

Mr. Shinichi Kunisaki has been serving as Director in ROHTO Pharmaceutical Co., Ltd., as well as President and Representative Director of a subsidiary, since June 2018. He joined the Company in January 2007. He used to work for Suntory Co., Ltd.

Hidetoshi Segi

Mr. Hidetoshi Segi has been serving as Chief Information Officer, Director of Business Planning and Director in ROHTO Pharmaceutical Co., Ltd. since June 2019. He joined the Company in June 1997.

Lekh Raj Juneja

Mr. Lekh Raj Juneja has been serving as Vice President, Chief Health Officer and Director in ROHTO Pharmaceutical Co., Ltd. since June 24, 2014. He joined the Company in April 2014. he used to work for Taiyo Kagaku Co., Ltd.

Masaya Saito

Mr. Masaya Saito has been serving as Vice President and Director in ROHTO Pharmaceutical Co., Ltd., as well as President and Director of a subsidiary, since June 2018. He joined the Company in April 1986. He previously served as Deputy Chief Director of Business Information in the Company.

Masako Rikiishi

Ms. Masako Rikiishi has been serving as Director of Product Marketing and Director in ROHTO Pharmaceutical Co., Ltd. since June 2018. She joined the Company in April 1982.

Hideto Uemura

Mr. Hideto Uemura has been serving as Director of Business Strategy Promotion Unit, Manager of Ueno Technology Center and Director in ROHTO Pharmaceutical Co., Ltd. since June 2018. He joined the Company in April 1982.

Tetsumasa Yamada

Mr. Tetsumasa Yamada has been serving as Director of Regenerative Medicine Research Planning and Director in ROHTO Pharmaceutical Co., Ltd. since June 2018. He joined the Company in August 2000.

Akie Iriyama

Mr. Akie Iriyama has been serving as Independent Director in ROHTO Pharmaceutical Co., Ltd., since June 2019. He is also serving as Independent Director in MACROMILL, INC., as well as Professor in Waseda University.

Mari Matsunaga

Ms. Mari Matsunaga has been serving as Independent Director in ROHTO Pharmaceutical Co., Ltd. since June 2014. She is also serving as Independent Director in MS & AD Insurance Group Holdings , Inc., BRAINS NETWORK CO., LTD., and SEIKO EPSON CORPORATION, and working for a Japan-based firm.

Shingo Torii

Mr. Shingo Torii has been serving as Independent Director in ROHTO Pharmaceutical Co., Ltd. since June 2015. He is also serving as Vice Chairman of the Board and Representative Director in Suntory Holdings Limited, as well as Director in Beam Suntory Inc.

Masumi Inoue